Senseonics (SENS) up 35% in past week on imminent FDA approval
Senseonics (SENS) is expected to have a response of FDA approval soon. Data presented in 2023 demonstrated strong accuracy with the 180-day sensor, as the next-generation Eversense matched performance levels compared to the current 90-day sensor available in the U.S.,…